|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
389,580,000 |
Market
Cap: |
45.11(B) |
Last
Volume: |
3,009,533 |
Avg
Vol: |
1,927,028 |
52
Week Range: |
$75.49 - $140.45 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 487 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile DexCom is a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems. Co.'s product candidates include Dexcom G7®, which is designed with the goal of carrying forward many of the same features as Co.'s G6 CGM system and adding several new or improved features. Co.'s products include: DexCom G6® integrated Continuous Glucose Monitoring System (G6), which is a type of CGM system to be used as part of an integrated system with other medical devices and electronic interfaces; and DexCom Share®, which transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
214,192 |
275,430 |
303,186 |
572,710 |
Total Sell Value |
$28,873,866 |
$36,403,178 |
$39,551,376 |
$69,690,287 |
Total People Sold |
7 |
9 |
14 |
15 |
Total Sell Transactions |
15 |
25 |
46 |
79 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Pacelli Steven Robert |
Managing Dir., Dexcom Ventures |
|
2021-05-24 |
4 |
AS |
$343.73 |
$376,260 |
D/D |
(1,079) |
52,321 |
|
56% |
|
Collins Richard Alexander |
Director |
|
2021-05-21 |
4 |
A |
$0.00 |
$1 |
D/D |
910 |
910 |
|
- |
|
Topol Eric |
Director |
|
2021-05-21 |
4 |
A |
$0.00 |
$1 |
D/D |
919 |
919 |
|
- |
|
Heller Bridgette P |
Director |
|
2021-05-21 |
4 |
A |
$0.00 |
$1 |
D/D |
919 |
4,367 |
|
- |
|
Malady Kyle |
Director |
|
2021-05-21 |
4 |
A |
$0.00 |
$1 |
D/D |
910 |
2,182 |
|
- |
|
Kahn Barbara |
Director |
|
2021-05-21 |
4 |
A |
$0.00 |
$1 |
D/D |
918 |
918 |
|
- |
|
Augustinos Nicholas |
Director |
|
2021-05-21 |
4 |
A |
$0.00 |
$1 |
D/D |
918 |
3,916 |
|
- |
|
Altman Steven R |
Director |
|
2021-05-21 |
4 |
A |
$0.00 |
$1 |
D/D |
910 |
910 |
|
- |
|
Skyler Jay S |
Director |
|
2021-05-21 |
4 |
A |
$0.00 |
$1 |
D/D |
900 |
900 |
|
- |
|
Foletta Mark G |
Director |
|
2021-05-21 |
4 |
A |
$0.00 |
$1 |
D/D |
1,054 |
1,054 |
|
- |
|
Dahut Karen M |
Director |
|
2021-05-21 |
4 |
A |
$0.00 |
$1 |
D/D |
918 |
2,078 |
|
- |
|
Collins Richard Alexander |
Director |
|
2021-05-20 |
4 |
A |
$0.00 |
$0 |
I/I |
787 |
8,704 |
|
- |
|
Collins Richard Alexander |
Director |
|
2021-05-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(787) |
0 |
|
- |
|
Topol Eric |
Director |
|
2021-05-20 |
4 |
A |
$0.00 |
$0 |
I/I |
833 |
91,847 |
|
- |
|
Topol Eric |
Director |
|
2021-05-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(833) |
0 |
|
- |
|
Kahn Barbara |
Director |
|
2021-05-20 |
4 |
A |
$0.00 |
$0 |
I/I |
787 |
7,666 |
|
- |
|
Kahn Barbara |
Director |
|
2021-05-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(787) |
0 |
|
- |
|
Altman Steven R |
Director |
|
2021-05-20 |
4 |
A |
$0.00 |
$0 |
I/I |
806 |
13,786 |
|
- |
|
Altman Steven R |
Director |
|
2021-05-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(806) |
0 |
|
- |
|
Skyler Jay S |
Director |
|
2021-05-20 |
4 |
A |
$0.00 |
$0 |
I/I |
822 |
33,968 |
|
- |
|
Skyler Jay S |
Director |
|
2021-05-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(822) |
0 |
|
- |
|
Foletta Mark G |
Director |
|
2021-05-20 |
4 |
A |
$0.00 |
$0 |
I/I |
895 |
14,097 |
|
- |
|
Foletta Mark G |
Director |
|
2021-05-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(895) |
0 |
|
- |
|
Sayer Kevin R |
Chairman, CEO & President |
|
2021-05-03 |
4 |
AS |
$376.33 |
$2,102,626 |
D/D |
(5,535) |
105,722 |
|
44% |
|
Murphy Patrick Michael |
EVP, Chief Legal Officer |
|
2021-04-26 |
4 |
AS |
$415.83 |
$207,915 |
D/D |
(500) |
19,241 |
|
29% |
|
2303 Records found
|
|
Page 14 of 93 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|